From a drug’s discovery until it gains FDA approval there is an average of 10 to 15 years. An average of $2.6 billion in investments is needed along a drug’s development lifecycle. Both of these components deem the biopharma R&D cycle an anomaly in the world we live in, where everything is on-demand. In order […]